Project Details
Project Description
Multi-center, double-blind, randomized, placebo-controlled, parallel group study of evolocumab added to statin therapy for 24 months post-operatively in a broad population of patients undergoing CABG surgery.
| Short title | NEWTON-CABG |
|---|---|
| Status | Finished |
| Effective start/end date | 22/03/21 → 8/06/24 |
Funding
- Unity Health Toronto
Keywords
- cabg
- saphenous vein graft
- lipid
- statin
- cholesterol
Clinical Trial Phase
- Phase IV
- Sponsor is Monash University